Home / Inspections / 1095224

FDA Inspection 1095224 — Carter BloodCare - Addison

Carter BloodCare - Addison — FEI 3003755235

The FDA completed an inspection of Carter BloodCare - Addison on June 19, 2019 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Addison, TX (United States)

Facility

Other inspections at this facility

  • 1006380 (NAI Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938893 (NAI Mon Jul 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 822165 (NAI Wed Mar 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 719248 (NAI Fri Apr 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 576200 (VAI Fri Apr 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources